Bayesian Capital Management LP Buys Shares of 38,600 LifeStance Health Group, Inc. (NASDAQ:LFST)

Bayesian Capital Management LP bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund bought 38,600 shares of the company’s stock, valued at approximately $238,000.

Several other institutional investors and hedge funds also recently made changes to their positions in LFST. Bessemer Group Inc. increased its position in shares of LifeStance Health Group by 43.4% in the 1st quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock valued at $56,000 after buying an additional 2,768 shares in the last quarter. Assetmark Inc. increased its position in shares of LifeStance Health Group by 21.6% in the 4th quarter. Assetmark Inc. now owns 11,895 shares of the company’s stock valued at $93,000 after buying an additional 2,114 shares in the last quarter. Stratos Wealth Partners LTD. bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at $93,000. Allen Investment Management LLC bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at $79,000. Finally, ProShare Advisors LLC increased its position in shares of LifeStance Health Group by 8.5% in the 1st quarter. ProShare Advisors LLC now owns 19,069 shares of the company’s stock valued at $118,000 after buying an additional 1,500 shares in the last quarter. Institutional investors own 85.50% of the company’s stock.

Analysts Set New Price Targets

Separately, Morgan Stanley reaffirmed an “overweight” rating and issued a $10.00 target price on shares of LifeStance Health Group in a research note on Monday, April 22nd. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, LifeStance Health Group currently has a consensus rating of “Hold” and an average target price of $8.80.

LifeStance Health Group Stock Up 1.8 %

Shares of NASDAQ LFST opened at $5.61 on Friday. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.20. LifeStance Health Group, Inc. has a 1-year low of $4.64 and a 1-year high of $9.45. The company has a fifty day moving average price of $5.39 and a 200 day moving average price of $6.14.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, May 9th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.03. LifeStance Health Group had a negative net margin of 15.69% and a negative return on equity of 11.92%. The company had revenue of $300.44 million during the quarter, compared to the consensus estimate of $299.02 million. During the same period in the prior year, the business posted ($0.09) EPS. The company’s quarterly revenue was up 18.9% on a year-over-year basis. As a group, equities analysts expect that LifeStance Health Group, Inc. will post -0.25 EPS for the current year.

Insider Transactions at LifeStance Health Group

In other news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total transaction of $22,395,812.05. Following the completion of the transaction, the insider now directly owns 41,932,358 shares in the company, valued at approximately $246,981,588.62. The transaction was disclosed in a document filed with the SEC, which is available at this link. In related news, major shareholder Summit Partners Growth Equity sold 3,802,345 shares of the firm’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $5.89, for a total value of $22,395,812.05. Following the completion of the sale, the insider now directly owns 41,932,358 shares in the company, valued at approximately $246,981,588.62. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Danish J. Qureshi sold 150,000 shares of the firm’s stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $5.21, for a total transaction of $781,500.00. Following the completion of the sale, the insider now owns 439,002 shares of the company’s stock, valued at $2,287,200.42. The disclosure for this sale can be found here. Insiders sold a total of 4,087,716 shares of company stock worth $24,010,444 in the last three months. Insiders own 6.60% of the company’s stock.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.